L. Console-Bram, J. Marcu, M. E. Abood: Cannabinoid receptors: nomenclature and pharmacological principles.In: Progress in Neuro-Psychopharmacology & Biological Psychiatry.Band 38, Nummer 1, Juli 2012, S. 4–15, ISSN 1878-4216. doi:10.1016/j.pnpbp.2012.02.009, PMID 22421596, PMC 3378782
GPR119 G protein-coupled receptor 119 (human).In: ncbi.nlm.nih.gov.Abgerufen am 18. Dezember 2015.
GPR18 G protein-coupled receptor 18 (human).In: ncbi.nlm.nih.gov.Abgerufen am 18. Dezember 2015.
GPR55 G protein-coupled receptor 55 (human).In: ncbi.nlm.nih.gov.Abgerufen am 18. Dezember 2015.
A. J. Brown: Novel cannabinoid receptors.In: British journal of pharmacology.Band 152, Nummer 5, November 2007, S. 567–575, doi:10.1038/sj.bjp.0707481, PMID 17906678, PMC 2190013(Review).
D. McHugh, S. S. Hu, N. Rimmerman, A. Juknat, Z. Vogel, J. M. Walker, H. B. Bradshaw: N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.In: BMC neuroscience.Band 11, 2010, S. 44, doi:10.1186/1471-2202-11-44, PMID 20346144, PMC 2865488
P.E. Castillo, T. J. Younts, A. E. Chávez, Y. Hashimotodani: Endocannabinoid signaling and synaptic function.In: Neuron.Band 76, Nummer 1, Oktober 2012, S. 70–81, ISSN1097-4199. doi:10.1016/j.neuron.2012.09.020, PMID 23040807, PMC 3517813
S. Ruehle, A. A. Rey, F. Remmers, B. Lutz: The endocannabinoid system in anxiety, fear memory and habituation.In: Journal of Psychopharmacology.Band 26, Nummer 1, Januar 2012, S. 23–39, ISSN1461-7285. doi:10.1177/0269881111408958, PMID 21768162, PMC 3267552
Giovanni Marsicano, Carsten T. Wotjak, Shahnaz C. Azad, Tiziana Bisogno, Gerhard Rammes, Maria Grazia Cascio, Heike Hermann, Jianrong Tang, Clementine Hofmann, Walter Zieglgänsberger, Vincenzo Di Marzo, Beat Lutz: The endogenous cannabinoid system controls extinction of aversive memories.In: Nature.418, 2002, S. 530, doi:10.1038/nature00839.
Eva Hoch, Miriam Schneider, Chris Maria Friemel (Hrsg.): Cannabis: Potenzial und Risiko – Eine wissenschaftliche Bestandsaufnahme. Springer, Heidelberg 2019, ISBN 978-3-662-57291-7, doi:10.1007/978-3-662-57291-7(478 S.,bundesgesundheitsministerium.de[PDF])., Kurzbericht, 8 S., PDF
Sabine Lebel-Hardenack, Sarah R. Grant: Genetics of sex determination in flowering plants. In: Trends in Plant Science. Band 2, Nr. 4, April 1997, ISSN 1360-1385, S. 130–136, doi:10.1016/S1360-1385(97)01012-1.
Paul G. Mahlberg, Eun Soo Kim: THC (tetrahydrocannabinol) accumulation in glands of Cannabis (Cannabaceae). In: The Hemp Report, 3 (17), 2001. Gelesen am 23. Februar 2007.
Braz J Psychiatry.2006 Jun;28(2):153-7. Epub 2006 Jun 26.History of cannabis as a medicine: a review.
Chem Biodivers.2007 Aug;4(8):1614-48. History of cannabis and its preparations in saga, science, and sobriquet.
Legal and Regulatory Issues Governing Cannabisand Cannabis-Derived Products in the United States. Mead A. Front Plant Sci. 2019 Jun 14;10:697. doi: 10.3389/fpls.2019.00697. eCollection 2019. Review.
Roger G. Pertwee: Pharmacological and therapeutic targets for Δ9-tetrahydrocannabinol and cannabidiol. In: Euphytica. Band 140, Nr. 1–2, 2004, S. 73–82, doi:10.1007/s10681-004-4756-9.
Yehiel Gaoni, Raphael Mechoulam: Isolation, structure and partial synthesis of an active constituent of hashish. In:Journal of the American Chemical Society. Band 86, Nr. 8, 1964, S. 1646–1647, doi:10.1021/ja01062a046.
Thomas, G. L. Baillie, A. M. Phillips, R. K. Razdan, R. A. Ross, R. G. Pertwee: Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.In: Br. J. Pharmacol.150, 5, 2007, S. 613–623, doi:10.1038/sj.bjp.0707133. PMID 17245363.
O. Devinsky, J. H. Cross, L. Laux u. a.: Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome.In: New England Journal of Medicine. Band 376, 2017, S. 2011–2020.